Cellective BioTherapy, Inc. — Form D

Cellective BioTherapy, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-28. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2015-05-28
• Form: D
• Accession: 0001643495-15-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.5M
• Investors: 2
• Date of first sale: 2015-05-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-240663

Issuer

• Name: Cellective BioTherapy, Inc.
• CIK: 0001643495
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 6 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
• Phone: 919-684-3681

Officers, directors & promoters (6)

More

• CIK 1643495 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search